Current Gene Therapy
Title:Editorial [Hot Topic :The Therapeutic Sound of Silencing: Managing the Expectations on Targeting RNAi]
Volume: 12 Issue: 4
Author(s): Alexandra Henrion-Caude
Affiliation:
Export Options
About this article
Cite this article as:
Henrion-Caude Alexandra, Editorial [Hot Topic :The Therapeutic Sound of Silencing: Managing the Expectations on Targeting RNAi], Current Gene Therapy 2012; 12 (4) . https://dx.doi.org/10.2174/156652312802083567
DOI https://dx.doi.org/10.2174/156652312802083567 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
TRPV1 Antagonists as a Potential Treatment for Hyperalgesia
Recent Patents on CNS Drug Discovery (Discontinued) Using Microgravity for Defining Novel Anti-Atherosclerotic Therapy
Current Genomics Genetically Redirected T Lymphocytes for Adoptive Immunotherapy of Solid Tumors
Current Gene Therapy Relevant Physicochemical Descriptors of “Soft Nanomedicines” to Bypass Biological Barriers
Current Pharmaceutical Design Discovery and Development of Anti-HIV Therapeutic Agents: Progress Towards Improved HIV Medication
Current Topics in Medicinal Chemistry Functions of Antimicrobial Peptides in Vertebrates
Current Protein & Peptide Science Adenosine Monophosphate-activated Protein Kinase (AMPK) Activators For the Prevention, Treatment and Potential Reversal of Pathological Pain
Current Drug Targets Nonalcoholic Fatty Liver Disease (NAFLD) for Primary Care Providers: Beyond the Liver
Current Hypertension Reviews Mammary Development and Breast Cancer: The Role of Stem Cells
Current Molecular Medicine Biomolecules for Removal of Heavy Metal
Recent Patents on Biotechnology Progress of HDAC Inhibitor Panobinostat in the Treatment of Cancer
Current Drug Targets Manufacturing and Regulatory Strategies for Clinical AAV2-hRPE65
Current Gene Therapy Inflammatory Process in Parkinsons Disease: Role for Cytokines
Current Pharmaceutical Design HPV Vaccination in Women Above 25 Years: Reasons Why?
Current Cancer Therapy Reviews The Rb Pathway and Cancer Therapeutics
Current Drug Targets Anti-cancer and Other Bioactivities of Korean Angelica gigas Nakai (AGN) and Its Major Pyranocoumarin Compounds
Anti-Cancer Agents in Medicinal Chemistry Flavonoids, Vascular Function and Cardiovascular Protection
Current Pharmaceutical Design Towards Improved Therapies Using Nanopharmaceuticals: Recent Patents on Pharmaceutical Nanoformulations
Recent Patents on Food, Nutrition & Agriculture Inhibition of Cyclin-Dependent Kinases - A Review of the Recent Patent Literature
Recent Patents on Anti-Cancer Drug Discovery Selective Inhibitors of Zinc-Dependent Histone Deacetylases. Therapeutic Targets Relevant to Cancer
Current Pharmaceutical Design